Clinical Trial

Octreotide Microspheres for Preventing Pancreatic Fistula

Name: Octreotide Microspheres for Preventing Pancreatic Fistula — clinical trial record (NCT07479784)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study is a randomized, double-blind, placebo-controlled, multicenter phase III clinical trial designed to evaluate the efficacy and safety of octreotide microspheres in preventing pancreatic fistula after distal pancreatectomy.

Trial Details

NCT Number	NCT07479784
Lead Sponsor	Shanghai Zhongshan Hospital
Conditions	Pancreatic Fistula
Enrollment	230 participants
Start Date	2026-04-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-18